MedPath

Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors

Not Applicable
Withdrawn
Conditions
Childhood Brain Tumor
Childhood Non-Hodgkin Lymphoma
Childhood Hodgkin Lymphoma
Malignant Childhood Neoplasm
Interventions
Behavioral: Specimen Collection/Risk Factor Assessment -> Diet/Exercise -> Chemotherapy
Registration Number
NCT02000986
Lead Sponsor
Virginia Commonwealth University
Brief Summary

This clinical trial studies dietary and exercise interventions in preventing cardiovascular disease in younger survivors of childhood cancer. Eating a healthy diet and exercising regularly may reduce the risk of cardiovascular disease in younger survivors of childhood cancer.

Detailed Description

Participants receive personalized exercise plan and prescription tailored to individual needs and current level of activity and fitness, and they also receive 2 one-hour individual exercise training sessions consisting of 20-30 minutes cardiovascular activity and strength training. Participants receive nutritional education consisting of energy balance, appropriate portion sizes, calorie count, and basic nutrition skills such as label reading every 2 weeks for 12 weeks.

After completion of study treatment, patients are followed for up to 6 months.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Diagnosis of pediatric cancer
  • Patients 3 months to 1 year after completion of therapy
Exclusion Criteria
  • Patients who are already on antihypertensive or insulin or cholesterol lowering medication
  • Patients who have not been evaluated for exercise tolerance and cleared by their physician for participation
  • Inability to understand program instructions due to language barrier or mental disability
  • Unable to participate in the outlined exercise program due to a physical disability

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Specimen Collection/Risk Factor Assessment -> Diet/Exercise ->Specimen Collection/Risk Factor Assessment -> Diet/Exercise -> ChemotherapySpecimen Collection/Risk Factor Assessment -\> Diet/Exercise -\> Chemotherapy
Primary Outcome Measures
NameTimeMethod
Feasibility determined by average attendance and retentionAt 3 months

Acceptability will be determined by responses on feedback measures and qualitative analysis of exit interviews.

Secondary Outcome Measures
NameTimeMethod
Feasibility determined by average attendance and retention from the blood pressure at enrollmentAt 6 months

Will be assessed via paired T test.

Acceptability level at time of enrollmentAt 6 months

Acceptability will be determined by responses on feedback measures and qualitative analysis of exit interviews.

© Copyright 2025. All Rights Reserved by MedPath